The english version of the website is under development. Wherever text appears in Greek, it means it has not been translated yet.

Publications

Κατάλογος ενδεικτικών δημοσιεύσεων του τμήματος Ιατρικής ΑΠΘ σε διεθνή επιστημονικά περιοδικά κατά τα τελευταία 5 έτη.

Export 61 results:
Author Title Type [ Year(Asc)]
Filters: Keyword is Liver Neoplasms  [Clear All Filters]
2020
Polyzos, S. A., Kountouras J., Goulas A., & Duntas L. (2020).  Selenium and selenoprotein P in nonalcoholic fatty liver disease.. Hormones (Athens). 19(1), 61-72.
2019
Tsalis, K., Parpoudi S., Kyziridis D., Ioannidis O., Savvala N-A., Antoniou N., et al. (2019).  Klatskin tumors and "Klatskin-mimicking lesions": our 22-year experience.. Rev Esp Enferm Dig. 111(2), 121-128.
Malousi, A., Kouidou S., Tsagiopoulou M., Papakonstantinou N., Bouras E., Georgiou E., et al. (2019).  MeinteR: A framework to prioritize DNA methylation aberrations based on conformational and cis-regulatory element enrichment.. Sci Rep. 9(1), 19148.
2018
Tsalis, K., Ioannidis O., Cheva A., Savvala N. Antigoni, Antoniou N., Parpoudi S., et al. (2018).  A 20-year single center experience in the surgical treatment of colorectal liver metastasis.. J BUON. 23(6), 1640-1647.
Pentheroudakis, G., Kotoula V., Koliou G-A., Karavasilis V., Samantas E., Aravantinos G., et al. (2018).  AMALTHEA: Prospective, Single-Arm Study of the Hellenic Cooperative Oncology Group (HeCOG) Evaluating Efficacy and Safety of First-Line FOLFIRI + Aflibercept for 6 Months Followed by Aflibercept Maintenance in Patients With Metastatic Colorectal Cancer.. Clin Colorectal Cancer. 17(4), e631-e637.
Ioannidis, O., Chatzidelios C., Mantzoros I., Tatsis D., Kitsikosta L., Chatzakis C., et al. (2018).  [Polymetastatic highly aggressive Small Cell Undifferentiated Neuroendocrine Carcinoma of Ascending Colon].. Cir Cir. 86(5), 446-449.
Konstantinidis, I. T., Nota C., Jutric Z., Ituarte P., Chow W., Chu P., et al. (2018).  Primary liver sarcomas in the modern era: Resection or transplantation?. J Surg Oncol. 117(5), 886-891.
Gkika, E., Bettinger D., Krafft L., Schultheiss M., Neeff H. Philipp, Maruschke L., et al. (2018).  The role of albumin-bilirubin grade and inflammation-based index in patients with hepatocellular carcinoma treated with stereotactic body radiotherapy.. Strahlenther Onkol. 194(5), 403-413.
2017
Neofytou, K., Giakoustidis A., Neves M. Costa, Morrison D., Giakoustidis D., Khan A. Z., et al. (2017).  Increased carcinoembryonic antigen (CEA) following neoadjuvant chemotherapy predicts poor prognosis in patients that undergo hepatectomy for liver-only colorectal metastases.. Langenbecks Arch Surg. 402(4), 599-605.
T Kingham, P., Nguyen H. C. B., Zheng J., Konstantinidis I. T., Sadot E., Shia J., et al. (2017).  MicroRNA-203 predicts human survival after resection of colorectal liver metastasis.. Oncotarget. 8(12), 18821-18831.
Pardo, F., Sangro B., Lee R-C., Manas D., Jeyarajah R., Donckier V., et al. (2017).  The Post-SIR-Spheres Surgery Study (P4S): Retrospective Analysis of Safety Following Hepatic Resection or Transplantation in Patients Previously Treated with Selective Internal Radiation Therapy with Yttrium-90 Resin Microspheres.. Ann Surg Oncol. 24(9), 2465-2473.
Bettinger, D., Spode R., Glaser N., Buettner N., Boettler T., Neumann-Haefelin C., et al. (2017).  Survival benefit of transarterial chemoembolization in patients with metastatic hepatocellular carcinoma: a single center experience.. BMC Gastroenterol. 17(1), 98.
Hytiroglou, P. (2017).  Well-differentiated hepatocellular nodule: Making a diagnosis on biopsy and resection specimens of patients with advanced stage chronic liver disease.. Semin Diagn Pathol. 34(2), 138-145.
2016
Kudo, M., Lencioni R., Marrero J. A., Venook A. P., Bronowicki J-P., Chen X-P., et al. (2016).  Regional differences in sorafenib-treated patients with hepatocellular carcinoma: GIDEON observational study.. Liver Int. 36(8), 1196-205.
Quaglia, A., Alves V. A., Balabaud C., Bhathal P. S., Bioulac-Sage P., Crawford J. M., et al. (2016).  Role of aetiology in the progression, regression, and parenchymal remodelling of liver disease: implications for liver biopsy interpretation.. Histopathology. 68(7), 953-67.
Geschwind, J-F., Kudo M., Marrero J. A., Venook A. P., Chen X-P., Bronowicki J-P., et al. (2016).  TACE Treatment in Patients with Sorafenib-treated Unresectable Hepatocellular Carcinoma in Clinical Practice: Final Analysis of GIDEON.. Radiology. 279(2), 630-40.
2015
Giakoustidis, A., Giakoustidis D., Mudan S., Sklavos A., & Williams R. (2015).  Molecular signalling in hepatocellular carcinoma: Role of and crosstalk among WNT/ß-catenin, Sonic Hedgehog, Notch and Dickkopf-1.. Can J Gastroenterol Hepatol. 29(4), 209-17.
2014
Athyros, V. G., Katsiki N., Karagiannis A., & Mikhailidis D. P. (2014).  Are statins 'IDEAL' for non-alcoholic fatty liver disease?. Curr Med Res Opin. 30(2), 229-31.
Evrard, S., Poston G., Kissmeyer-Nielsen P., Diallo A., Desolneux G., Brouste V., et al. (2014).  Combined ablation and resection (CARe) as an effective parenchymal sparing treatment for extensive colorectal liver metastases.. PLoS One. 9(12), e114404.
Tsoulfas, G., Agorastou P., Tooulias A., & Marakis G. N. (2014).  Current and future challenges in the surgical treatment of hepatocellular carcinoma: a review.. Int Surg. 99(6), 779-86.
Daoudaki, M., & Fouzas I. (2014).  Hepatocellular carcinoma.. Wien Med Wochenschr. 164(21-22), 450-5.
Tsoulfas, G. (2014).  Role of microRNA in the diagnosis and therapy of hepatocellular carcinoma: a new frontier.. Microrna. 3(3), 137-43.
2013
Briasoulis, E., Aravantinos G., Kouvatseas G., Pappas P., Biziota E., Sainis I., et al. (2013).  Dose selection trial of metronomic oral vinorelbine monotherapy in patients with metastatic cancer: a hellenic cooperative oncology group clinical translational study.. BMC Cancer. 13, 263.
Hatzakis, A., Van Damme P., Alcorn K., Gore C., Benazzouz M., Berkane S., et al. (2013).  The state of hepatitis B and C in the Mediterranean and Balkan countries: report from a summit conference.. J Viral Hepat. 20 Suppl 2, 1-20.
2012
Zarogoulidis, K., Eleftheriadou E., Kontakiotis T., Gerasimou G., Zarogoulidis P., Sapardanis I., et al. (2012).  Long acting somatostatin analogues in combination to antineoplastic agents in the treatment of small cell lung cancer patients.. Lung Cancer. 76(1), 84-8.

Pages

Contact

Secretariat of the School of Medicine
 

Connect

School of Medicine's presence in social networks
Follow Us or Connect with us.